Target intelligence / Profile preview

microRNA 2115 (MIR2115)

Target
MIR2115
Molecular classification
microRNA, Non-coding RNA, Gene expression regulator
01

Overview

microRNA 2115 (MIR2115, hsa-mir-2115) is a small, single-stranded non-coding RNA molecule, typically 21–23 nucleotides in length, that functions as a post-transcriptional regulator of gene expression. Like other microRNAs, it binds to target messenger RNAs (mRNAs), primarily via partial complementarity to regions typically found in the 3′ untranslated region (3′-UTR), leading to mRNA degradation and/or inhibition of translation. Mir-2115 is part of the broad family of human microRNAs but is not currently classified as a major therapeutic target or established biomarker, and its specific biological and disease roles remain poorly characterized in available biomedical literature. MicroRNAs in general are involved in fine-tuning cellular responses, including cell proliferation, differentiation, and apoptosis, and have implications across multiple disease states, although the evidence for microRNA 2115 itself in these roles is limited. No specialized or validated molecular or clinical associations for microRNA 2115 are identified in current standard databases or primary literature.

Other names
MIR2115hsa-mir-2115microRNA 2115
02

Biological functions

Gene expression regulation (mRNA degradation, translation repression)Post-transcriptional modulationPotential involvement in cell cycle, differentiation, apoptosis, and other cell state transitions, as is typical for many miRNAs
03

Disease associations

Not specifically established; many miRNAs are implicated in cancer, cardiovascular disease, neurodegenerative disorders, inflammation, infection, and others, but MIR2115 itself is not well characterized in these contexts according to current public literature

Beyond the preview

Go deeper on microRNA 2115 (MIR2115).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on microRNA 2115 (MIR2115).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call